{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:33:22Z","timestamp":1783467202778,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,19]]},"DOI":"10.7759\/cureus.25137","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:40:31Z","timestamp":1652971231000},"source":"Crossref","is-referenced-by-count":3,"title":["Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?"],"prefix":"10.7759","author":[{"given":"Anmol","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dimitrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"\u2018Red flag\u2019 evaluation yield in irritable bowel syndrome","volume":"21","author":"Black TP","year":"2012","unstructured":"Black TP, Manolakis CS, Di Palma JA. \u2018Red flag\u2019 evaluation yield in irritable bowel syndrome. J Gastrointest Liver Dis. 2012, 21:153-6.","journal-title":"J Gastrointest Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i22.6759","article-title":"Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine","volume":"20","author":"Saha L","year":"2014","unstructured":"Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014, 20:6759-73. 10.3748\/wjg.v20.i22.6759","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy BE","year":"2017","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017, 6:99. 10.3390\/jcm6110099","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2016.07.006","article-title":"Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States","volume":"88","author":"Gudleski GD","year":"2017","unstructured":"Gudleski GD, Satchidanand N, Dunlap LJ, Tahiliani V, Li X, Keefer L, Lackner JM. Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States. Behav Res Ther. 2017, 88:65-75. 10.1016\/j.brat.2016.07.006","journal-title":"Behav Res Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)05656-3","article-title":"Evidence-based position statement on the management of irritable bowel syndrome in North America","volume":"97","author":"American College of Gastroenterology Functional Gastrointestinal Disorders Task Force","year":"2002","unstructured":"American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002, 97:S1-5. 10.1016\/S0002-9270(02)05656-3","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell RM","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012, 10:712-721.e4. 10.1016\/j.cgh.2012.02.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.646658","article-title":"Gastrointestinal symptoms and irritable bowel syndrome are associated with female sex and smoking in the general population and with unemployment in men","volume":"8","author":"Nilsson D","year":"2021","unstructured":"Nilsson D, Ohlsson B. Gastrointestinal symptoms and irritable bowel syndrome are associated with female sex and smoking in the general population and with unemployment in men. Front Med (Lausanne). 2021, 8:646658. 10.3389\/fmed.2021.646658","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14152","article-title":"Understanding racial disparities in the care of patients with irritable bowel syndrome: the need for a unified approach","volume":"33","author":"Sasegbon A","year":"2021","unstructured":"Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: the need for a unified approach. Neurogastroenterol Motil. 2021, 33:e14152. 10.1111\/nmo.14152","journal-title":"Neurogastroenterol Motil"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14039","article-title":"Racial disparity in healthcare utilization among patients with Irritable Bowel Syndrome: results from a multicenter cohort","volume":"33","author":"Silvernale C","year":"2021","unstructured":"Silvernale C, Kuo B, Staller K. Racial disparity in healthcare utilization among patients with Irritable Bowel Syndrome: results from a multicenter cohort. Neurogastroenterol Motil. 2021, 33:e14039. 10.1111\/nmo.14039","journal-title":"Neurogastroenterol Motil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1665095","article-title":"Lower socioeconomic status is associated with an increased prevalence of comorbid anxiety and depression among patients with irritable bowel syndrome: results from a multicenter cohort","volume":"54","author":"Silvernale C","year":"2019","unstructured":"Silvernale C, Kuo B, Staller K. Lower socioeconomic status is associated with an increased prevalence of comorbid anxiety and depression among patients with irritable bowel syndrome: results from a multicenter cohort. Scand J Gastroenterol. 2019, 54:1070-4. 10.1080\/00365521.2019.1665095","journal-title":"Scand J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12066","article-title":"Effect of insurance status on patients admitted for acute diverticulitis","volume":"15","author":"Mills AM","year":"2013","unstructured":"Mills AM, Holena DN, Kallan MJ, Carr BG, Reinke CE, Kelz RR. Effect of insurance status on patients admitted for acute diverticulitis. Colorectal Dis. 2013, 15:613-20. 10.1111\/codi.12066","journal-title":"Colorectal Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/107755870005700302","article-title":"Gaining and losing health insurance: strengthening the evidence for effects on access to care and health outcomes","volume":"57","author":"Kasper JD","year":"2000","unstructured":"Kasper JD, Giovannini TA, Hoffman C. Gaining and losing health insurance: strengthening the evidence for effects on access to care and health outcomes. Med Care Res Rev. 2000, 57:298-318; discussion 319-25. 10.1177\/107755870005700302","journal-title":"Med Care Res Rev"},{"key":"ref13","unstructured":"CPI inflation calculator. (2022). Accessed. May 7, 2022: https:\/\/www.bls.gov\/data\/inflation_calculator.htm."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.13082","article-title":"Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders","volume":"23","author":"Chuah KH","year":"2022","unstructured":"Chuah KH, Cheong SY, Lim SZ, Mahadeva S. Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders. J Dig Dis. 2022, 23:111-7. 10.1111\/1751-2980.13082","journal-title":"J Dig Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00883-X","article-title":"Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms","volume":"111","author":"Annibale B","year":"2001","unstructured":"Annibale B, Capurso G, Chistolini A, D\u2019Ambra G, DiGiulio E, Monarca B, DelleFave G. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med. 2001, 111:439-45. 10.1016\/S0002-9343(01)00883-X","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000488","article-title":"Colorectal cancer screening in hospitalized patients: results from the Nationwide Inpatient Sample","volume":"28","author":"Eke R","year":"2019","unstructured":"Eke R, Tariq T, Li T, Irfan FB. Colorectal cancer screening in hospitalized patients: results from the Nationwide Inpatient Sample. Eur J Cancer Prev. 2019, 28:413-9. 10.1097\/CEJ.0000000000000488","journal-title":"Eur J Cancer Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101211","article-title":"Rational investigations in irritable bowel syndrome","volume":"11","author":"Black CJ","year":"2020","unstructured":"Black CJ, Ford AC. Rational investigations in irritable bowel syndrome. Frontline Gastroenterol. 2020, 11:140-7. 10.1136\/flgastro-2019-101211","journal-title":"Frontline Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.3.369","article-title":"Cost-effectiveness of endoscopy in irritable bowel syndrome","volume":"161","author":"Suleiman S","year":"2001","unstructured":"Suleiman S, Sonnenberg A. Cost-effectiveness of endoscopy in irritable bowel syndrome. Arch Intern Med. 2001, 161:369-75. 10.1001\/archinte.161.3.369","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.212","article-title":"Overuse of screening colonoscopy in the Medicare population","volume":"171","author":"Goodwin JS","year":"2011","unstructured":"Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011, 171:1335-43. 10.1001\/archinternmed.2011.212","journal-title":"Arch Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2912","article-title":"Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region","volume":"173","author":"Sheffield KM","year":"2013","unstructured":"Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med. 2013, 173:542-50. 10.1001\/jamainternmed.2013.2912","journal-title":"JAMA Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788795","article-title":"Epidemiology, clinical features, and prescribing patterns of irritable bowel syndrome in Taiwan","volume":"12","author":"Lai YT","year":"2021","unstructured":"Lai YT, Chen CY, Bair MJ. Epidemiology, clinical features, and prescribing patterns of irritable bowel syndrome in Taiwan. Front Pharmacol. 2021, 12:788795. 10.3389\/fphar.2021.788795","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3920\/BM2012.0007","article-title":"Cost\/benefit of synbiotics in acute infectious gastroenteritis: spend to save","volume":"3","author":"Vandenplas Y","year":"2012","unstructured":"Vandenplas Y, De Hert S. Cost\/benefit of synbiotics in acute infectious gastroenteritis: spend to save. Benef Microbes. 2012, 3:189-94. 10.3920\/BM2012.0007","journal-title":"Benef Microbes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck P","year":"2016","unstructured":"Enck P, Aziz Q, Barbara G, et al.. Irritable bowel syndrome. Nat Rev Dis Primers. 2016, 2:16014. 10.1038\/nrdp.2016.14","journal-title":"Nat Rev Dis Primers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97634-do-socio-demographics-play-a-role-in-the-prevalence-of-red-flags-and-pursuant-colonoscopies-in-patients-with-irritable-bowel-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:37Z","timestamp":1707507817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97634-do-socio-demographics-play-a-role-in-the-prevalence-of-red-flags-and-pursuant-colonoscopies-in-patients-with-irritable-bowel-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.25137","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}